Ronald Bailey on How to Save Lives by Getting the FDA into the 21st Century
"FDA is relying on 20th century regulatory science to evaluate 21st century medical products," declared Food and Drug Administration Commissioner Margaret Hamburg back in October 2010. One result: As biotech and medical discoveries accelerate the number of new drugs approved by the agency remains basically flat. Reason Science Correspondent Ronald Bailey thinks that a new Manhattan Institute study arguing for the conditional approval of new drugs as a way to speed access to patients is on the right track.
Hide Comments (0)
Editor's Note: As of February 29, 2024, commenting privileges on reason.com posts are limited to Reason Plus subscribers. Past commenters are grandfathered in for a temporary period. Subscribe here to preserve your ability to comment. Your Reason Plus subscription also gives you an ad-free version of reason.com, along with full access to the digital edition and archives of Reason magazine. We request that comments be civil and on-topic. We do not moderate or assume any responsibility for comments, which are owned by the readers who post them. Comments do not represent the views of reason.com or Reason Foundation. We reserve the right to delete any comment and ban commenters for any reason at any time. Comments may only be edited within 5 minutes of posting. Report abuses.
Please
to post commentsMute this user?
Ban this user?
Un-ban this user?
Nuke this user?
Un-nuke this user?
Flag this comment?
Un-flag this comment?